Norfloxacin Adult Dosage
For uncomplicated urinary tract infections (UTIs), the standard adult dose of norfloxacin is 400 mg orally twice daily for 7-10 days, though 800 mg once daily is equally effective. For uncomplicated gonorrhea, norfloxacin 800 mg as a single oral dose is recommended as an alternative regimen, though it offers no advantage over preferred fluoroquinolones like ciprofloxacin.
Urinary Tract Infections
Uncomplicated Cystitis
- Standard dosing: 400 mg orally twice daily for 7-10 days 1, 2
- Alternative once-daily dosing: 800 mg orally once daily for 7-10 days 1
The once-daily 800 mg regimen demonstrates equivalent clinical efficacy (95.3% vs 100%) and bacteriological efficacy (92.0% vs 95.5%) compared to the twice-daily 400 mg regimen, with no statistically significant differences in adverse events 1. The once-daily regimen may improve patient compliance while maintaining therapeutic effectiveness.
Duration Considerations
Seven-day treatment is superior to 3-day treatment for uncomplicated UTIs. A randomized trial showed accumulated efficacy of 91.7% with 7-day treatment versus 81.3% with 3-day treatment (p<0.004) 2. While both regimens achieve similar short-term bacteriuria elimination (96.6% vs 93.8%), the longer duration provides better sustained cure rates.
Single-dose therapy (800 mg) is inferior to multi-day regimens, particularly for non-E. coli infections. Single-dose therapy shows only 78% cure rate at 4-6 weeks versus 88% with 3-day therapy, with notably poor efficacy against Staphylococcus saprophyticus 3.
Gonococcal Infections
Uncomplicated Urogenital/Anorectal Gonorrhea
Important caveat: Norfloxacin is listed only as an alternative quinolone regimen in CDC guidelines 4, 5. The guidelines explicitly state that norfloxacin "appears to be safe and effective for the treatment of uncomplicated gonorrhea, but data regarding their use are limited. None of the regimens appear to offer any advantage over ciprofloxacin at a dose of 500 mg or ofloxacin at 400 mg" 5.
Critical resistance warning: By 2006, fluoroquinolones including norfloxacin were no longer universally effective against N. gonorrhoeae in the United States due to quinolone-resistant N. gonorrhoeae (QRNG) 6. Current practice strongly favors cephalosporins (ceftriaxone 125 mg IM or cefixime 400 mg orally) over any fluoroquinolone for gonorrhea treatment.
Special Populations
Renal Impairment
While the evidence provided focuses on ofloxacin rather than norfloxacin specifically, fluoroquinolone dosing generally requires adjustment in renal dysfunction. Consult specific norfloxacin prescribing information for patients with creatinine clearance <50 mL/min.
Elderly Patients
No specific dose adjustment is mentioned for age alone, but elderly patients have increased risk of tendon disorders with fluoroquinolones and require renal function assessment for appropriate dosing.
Common Pitfalls
Avoid single-dose therapy for UTIs: Despite convenience, single-dose norfloxacin shows inferior cure rates, especially for non-E. coli pathogens 3
Do not use for gonorrhea as first-line: Norfloxacin is outdated for gonorrhea due to widespread resistance; cephalosporins are now standard 6
Consider local resistance patterns: The efficacy of norfloxacin for UTIs depends on local E. coli susceptibility patterns
Duration matters: Seven-day treatment provides significantly better sustained cure rates than shorter courses for UTIs 2